Adjuvant Therapy

Tumor Board # 70Jun 30, 2026

Diagnosis & Initial Management of Neuroendocrine Tumors

with Dr. Chih-Yi Liao, Dr. Xavier Keutgen, Dr. Lingling Du

How do you unravel the complexity of diagnosing and managing neuroendocrine tumors, where every case demands a tailored approach? In this episode of BackTable Tumor Board, host Dr. Lingling Du is joined by Dr. Chih-Yi Liao and Dr. Xavier Keutgen to break down the essential steps from first symptoms to staging, imaging, and early treatment decisions for NET patients. The discussion covers the spectrum of NET biology, individualized imaging strategies, and when surgery or systemic therapy is the best path forward.

Tumor Board # 55Apr 14, 2026

Updates in Colorectal Cancer Management: Insights from ASCO GI

with Dr. Shruti Patel, Dr. Jun Gong

How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco impact patient care and therapeutic strategies? Medical oncologists Dr. Shruti Patel and Dr. Jun Gong dissect evidence from multiple practice-changing studies, translating complex data into practical recommendations.

ENT & Allergy # 263Mar 3, 2026

Immunotherapy for Adults with RRP

with Dr. Aaron Friedman, Dr. Stephen Schoeff

Recurrent respiratory papillomatosis (RRP) has long been managed with repeated surgical debulking, sometimes requiring dozens of procedures over a lifetime. In this episode of BackTable, Dr. Aaron Friedman and guest host Dr. Stephen Schoeff discuss a major shift in care: immune-directed therapy targeting HPV 6 and 11.

Tumor Board # 49Feb 24, 2026

Inflammatory Breast Cancer: Symptoms, Diagnosis & Management

with Dr. Bora Lim, Dr. Lindsay Peterson

Inflammatory breast cancer (IBC) is rare but highly aggressive, and often hides in plain sight. Rather than presenting as the distinct lump, IBC typically appears as redness or swelling in the breast and skin changes that can mimic mastitis or infection, leading to dangerous delays in diagnosis. In this episode of BackTable Tumor Board, breast medical oncologists Dr. Lindsay Peterson and Dr. Bora Lim break down how to recognize IBC’s typical and atypical presentations, approach diagnostic workup, and tailor treatment across subtypes.

Urology # 221Mar 18, 2025

Perioperative Therapy for RCC: Updates & Challenges

with Dr. Sumanta Pal, Dr. Aditya Bagrodia

Sharpen your approach to high-risk renal cell carcinoma (RCC). In this episode of BackTable Urology, guest Dr. Sumanta (Monty) Pal from City of Hope joins host Dr. Aditya Bagrodia to discuss contemporary kidney cancer treatment and the complexities of perioperative therapy.

Urology # 103Jun 21, 2023

Adjuvant Therapy for High Risk Bladder Cancer

with Dr. Yair Lotan, Dr. Suzanne Cole

In this episode of BackTable Urology, Dr. Aditya Bagrodia invites Dr. Yair Lotan, professor of urologic oncology at UT Southwestern, and oncologist Dr. Suzanne Cole to discuss types of adjuvant treatment for high risk bladder cancer, including chemotherapy, radiation therapy, and immunotherapy.

Urology # 63Nov 4, 2022

Multidisciplinary Management of RCC

with Dr. Rana McKay, Dr. Raquibul Hannan, Dr. Phil Pierorazio

In this special episode, Dr. Phil Pierorazio (University of Pennsylvania) invites Dr. Rana McKay (UC San Diego) and Dr. Raquibul Hannan (UT Southwestern) about treatment options for renal cell carcinoma (RCC) patients in preparation for the 2022 International Kidney Cancer Symposium in Austin, Texas.

Urology # 56Sep 21, 2022

Adjuvant Therapy for Advanced Kidney Cancer: Who, What, When

with Dr. Rana McKay, Dr. Karim Bensalah, Dr. Aditya Bagrodia

In this episode of BackTable Urology, Dr. Aditya Bagrodia speaks with urologist Dr. Karim Bensalah from the Universitaire de Rennes and medical oncologist Dr. Rana McKay from UC San Diego about adjuvant therapy for advanced kidney cancer.